Overview
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency is a rare inherited immune disorder that makes a person unusually vulnerable to infections caused by mycobacteria. Mycobacteria are a group of germs that include the bacteria causing tuberculosis (TB) and a large family of environmental organisms called nontuberculous mycobacteria (NTM), which are normally harmless to most people. In this condition, the body's immune defense system does not respond properly to a key signaling molecule called interferon-gamma (IFN-gamma). Specifically, part of the receptor that detects IFN-gamma — called the IFN-gamma receptor 2 (IFNgammaR2) — does not work correctly, but it still has some remaining function (partial deficiency). Because the receptor is only partially impaired, the immune system can still mount some defense, which generally leads to a milder disease course compared to complete deficiency. Patients typically develop recurrent or severe infections with mycobacteria, including BCG disease after vaccination, disseminated nontuberculous mycobacterial infections, and sometimes tuberculosis. Other organisms such as Salmonella, certain fungi, and intracellular parasites may also cause unusual infections. Symptoms often include prolonged fevers, swollen lymph nodes, bone infections, lung infections, and skin lesions. The condition is usually diagnosed in childhood, though the age of onset can vary. Treatment focuses on aggressive and prolonged antibiotic therapy targeting the specific mycobacterial infection, and in some cases, supplemental interferon-gamma therapy may be used to boost the immune response. With appropriate management, many patients with partial deficiency have a better outlook than those with complete deficiency.
Also known as:
Key symptoms:
Recurrent or severe infections with mycobacteriaProlonged or unexplained feversSwollen lymph nodes that do not go awayLung infections or persistent coughBone infections (osteomyelitis)Skin nodules or abscessesSevere reaction to BCG vaccineWeight loss or failure to thrive in childrenFatigue and general weaknessInfections with Salmonella bacteriaLiver or spleen enlargementRecurrent infections that are hard to treat
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Childhood
Begins in childhood, roughly ages 1 to 12
Treatments
No FDA-approved treatments are currently listed for Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency.
Community
No community posts yet. Be the first to share your experience with Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency.
Start the conversation →Latest news about Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency
No recent news articles for Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.How severe is my (or my child's) IFNgammaR2 deficiency, and how much receptor function remains?,What infections should I watch for, and what are the early warning signs?,How long will antibiotic treatment need to continue?,Is interferon-gamma therapy recommended in our case, and is it available?,Should family members be genetically tested for this condition?,Are there any vaccines that should be avoided?,What precautions should we take in daily life to reduce infection risk?
Common questions about Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency
What is Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency?
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency is a rare inherited immune disorder that makes a person unusually vulnerable to infections caused by mycobacteria. Mycobacteria are a group of germs that include the bacteria causing tuberculosis (TB) and a large family of environmental organisms called nontuberculous mycobacteria (NTM), which are normally harmless to most people. In this condition, the body's immune defense system does not respond properly to a key signaling molecule called interferon-gamma (IFN-gamma). Specifically, par
How is Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency inherited?
Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency typically begin?
Typical onset of Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency is childhood. Age of onset can vary across affected individuals.